| 5th Jun 2024 7:00 am |
RNS |
Acquisition of Fusion completed |
| 3rd Jun 2024 3:05 pm |
RNS |
Block listing Interim Review |
| 3rd Jun 2024 3:00 pm |
RNS |
Total Voting Rights |
| 3rd Jun 2024 7:00 am |
RNS |
Tagrisso plus chemo recommended for approval in EU |
| 28th May 2024 7:00 am |
RNS |
Dato-DXd improved OS in nonsquamous lung cancer |
| 21st May 2024 7:00 am |
RNS |
AstraZeneca to deliver $80bn revenue by 2030 |
| 20th May 2024 7:00 am |
RNS |
AstraZeneca to manufacture ADCs in Singapore |
| 16th May 2024 7:00 am |
RNS |
SUPERNOVA Trial Met COVID-19 prevention endpoint |
| 15th May 2024 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 7th May 2024 7:00 am |
RNS |
AstraZeneca completes Cellectis equity investment |
| 2nd May 2024 7:00 am |
RNS |
Calquence combination improved PFS in 1L MCL |
| 1st May 2024 3:00 pm |
RNS |
Total Voting Rights |
| 29th Apr 2024 7:05 am |
RNS |
Truqap recommended for EU breast cancer approval |
| 29th Apr 2024 7:00 am |
RNS |
Enhertu improved PFS in HER2-low and ultralow |
| 25th Apr 2024 7:00 am |
RNS |
1st Quarter Results |
| 11th Apr 2024 5:30 pm |
RNS |
Result of AGM |
| 11th Apr 2024 7:00 am |
RNS |
AstraZeneca increases 2024 dividend by 7% |
| 8th Apr 2024 7:00 am |
RNS |
Enhertu approved in US for HER2+ solid tumours |
| 5th Apr 2024 7:00 am |
RNS |
Imfinzi improved OS & PFS in limited-stage SCLC |
| 2nd Apr 2024 3:00 pm |
RNS |
Total Voting Rights |
| 2nd Apr 2024 7:05 am |
RNS |
Voydeya approved in US |
| 2nd Apr 2024 7:00 am |
RNS |
FDA accepts Dato-DXd BLA for breast cancer |
| 25th Mar 2024 7:00 am |
RNS |
Ultomiris approved in the US for NMOSD |
| 19th Mar 2024 7:00 am |
RNS |
AstraZeneca to acquire Fusion |
| 14th Mar 2024 7:00 am |
RNS |
AstraZeneca to acquire Amolyt |
| 12th Mar 2024 11:00 am |
RNS |
Director/PDMR Shareholding |
| 7th Mar 2024 11:00 am |
RNS |
Notice of AGM |
| 6th Mar 2024 3:05 pm |
RNS |
Director/PDMR Shareholding |
| 6th Mar 2024 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 4th Mar 2024 7:00 am |
RNS |
EMA validates Dato-DXd MAAs for NSQ NSCLC and BC |
| 1st Mar 2024 3:00 pm |
RNS |
Total Voting Rights |
| 26th Feb 2024 7:00 am |
RNS |
Voydeya recommended for EU approval |
| 22nd Feb 2024 1:15 pm |
RNS |
Acquisition of Gracell completed |
| 22nd Feb 2024 11:00 am |
RNS |
Director/PDMR Shareholding |
| 22nd Feb 2024 7:00 am |
RNS |
AstraZeneca prices a $5bn bond offering |
| 21st Feb 2024 7:00 am |
RNS |
Filing of Form 20-F with SEC |
| 20th Feb 2024 11:00 am |
RNS |
Annual Financial Report |
| 19th Feb 2024 3:00 pm |
RNS |
AstraZeneca completes acquisition of Icosavax |
| 19th Feb 2024 7:10 am |
RNS |
Tagrisso plus chemo approved in US for lung cancer |
| 19th Feb 2024 7:05 am |
RNS |
FDA accepts Dato-DXd BLA for nonsquamous NSCLC |
